R. Razdan

J. Jallo, R. Tuma, M. Adler, 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Synthesis of 2-(5Z,8Z,11Z,14Z)-Icosa-5,8,11,14-tetraenamidoethyl-d(4) Dihydrogen Phosphate, Tetra-deuterated pAEA.

K. Rice, R. Razdan, B. Saha, 2008, Journal of labelled compounds & radiopharmaceuticals.

Influence of the degree of unsaturation of the acyl side chain upon the interaction of analogues of 1-arachidonoylglycerol with monoacylglycerol lipase and fatty acid amide hydrolase.

R. Pertwee, R. Razdan, B. Martin, 2005, Biochemical and biophysical research communications.

Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice.

T. Bonner, T. Sugiura, A. Zimmer, 2000, Hypertension.

Structure-activity relationships in cannabinoids.

R. Razdan, 1986, Pharmacological reviews.

The influence of beta-arrestin2 on cannabinoid CB1 receptor coupling to G-proteins and subcellular localization and relative levels of beta-arrestin1 and 2 in mouse brain

C. Breivogel, R. Razdan, J. Lambert, 2013, Journal of receptor and signal transduction research.

The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects

D. Selley, A. Lichtman, S. Kinsey, 2011, Neuropharmacology.

Pharmacological evaluation of dimethylheptyl analogs of delta 9-THC: reassessment of the putative three-point cannabinoid-receptor interaction.

R. L. Barrett, D. R. Compton, R. Razdan, 1995, Drug and alcohol dependence.

Synthesis of .beta.-dihydrothebaine

R. Razdan, D. E. Portlock, H. Dalzell, 1978 .

Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor.

R. Razdan, B. Martin, S. Batkai, 2003, Molecular pharmacology.

Cannabinoid properties of methylfluorophosphonate analogs.

D. Deutsch, V. Di Marzo, R. Razdan, 2000, The Journal of pharmacology and experimental therapeutics.

Cannabinoid Properties of Methylfluorophosphonate Analogs 1

D. Deutsch, V. Marzo, R. Razdan, 2000 .

6"-Azidohex-2"-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist.

R. Pertwee, R. Razdan, B. Saha, 2004, European journal of pharmacology.

Separation of cannabinoid receptor affinity and efficacy in delta‐8‐tetrahydrocannabinol side‐chain analogues

G. Griffin, R. Razdan, B. Martin, 2001, British journal of pharmacology.

Structural determinants of the partial agonist‐inverse agonist properties of 6′‐azidohex‐2′‐yne‐Δ8‐tetrahydrocannabinol at cannabinoid receptors

R. Pertwee, L. Stevenson, R. Razdan, 1999, British journal of pharmacology.

An investigation into the structural determinants of cannabinoid receptor ligand efficacy

G. Griffin, R. Razdan, B. Martin, 1999, British journal of pharmacology.

The Total Synthesis of Cannabinoids

R. Razdan, 2007 .

Hashish (1): Ceric ammonium nitrate oxidation of Δ6a, 1 0 a-tetrahydrocannabinols (THC's)

R. Razdan, P. Herlihy, H. Dalzell, 1976 .

Synthesis of novel 5-substituted pyrazole derivatives as cannabinoid antagonists

R. Razdan, B. Martin, A. Mahadevan, 2005 .

Resorcinol derivatives: a novel template for the development of cannabinoid CB(1)/CB(2) and CB(2)-selective agonists.

R. Razdan, B. Martin, A. Mahadevan, 2002, The Journal of pharmacology and experimental therapeutics.

Synthesis, pharmacology, and molecular modeling of novel 4-alkyloxy indole derivatives related to cannabimimetic aminoalkyl indoles (AAIs).

Aloke K. Dutta, B. Thomas, D. R. Compton, 1997, Bioorganic & medicinal chemistry.

Significance of cannabinoid CB1 receptors in improgan antinociception.

R. Razdan, B. Martin, M. Wentland, 2007, The journal of pain : official journal of the American Pain Society.

Comparison of cannabinoid binding sites in guinea‐pig forebrain and small intestine

R. Pertwee, R. Razdan, S. Fernando, 1998, British journal of pharmacology.

Agonist-antagonist characterization of 6'-cyanohex-2'-yne-delta 8-tetrahydrocannabinol in two isolated tissue preparations.

R. Pertwee, G. Griffin, D. R. Compton, 1996, European journal of pharmacology.

Sensitivity to Δ9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2−/− mice

C. Breivogel, R. Razdan, J. Lambert, 2008, Behavioural pharmacology.

An Improved Synthesis of Cannabinol and Cannabiorcol

R. Razdan, P. Meltzer, H. Dalzell, 1981 .

Further advances in the synthesis of endocannabinoid-related ligands

R. Razdan, A. Mahadevan, 2005, The AAPS Journal.

Novel, potent THC/anandamide (hybrid) analogs.

B. Thomas, R. Razdan, B. Martin, 2007, Bioorganic & medicinal chemistry.

Development of agonists, partial agonists and antagonists in the Δ8-Tetrahydrocannabinol series

R. Pertwee, R. Razdan, B. Martin, 1999 .

A Synthetic Route to Anandamide Analogues Carrying a Substituent at the Terminal Carbon and an Acetylene Group in the End Pentyl Chain

R. Altundas, R. Razdan, A. Mahadevan, 2004 .

A novel methodology for the synthesis of 1-desoxy-Δ8-tetrahydrocannabinol (THC) analogues

R. Razdan, A. Mahadevan, Hang Sun, 2004 .

Evaluation of Cannabimimetic Discriminative Stimulus Effects of Anandamide and Methylated Fluoroanandamide in Rhesus Monkeys

R. Razdan, B. Martin, W. Ryan, 1997, Pharmacology Biochemistry and Behavior.

Structural requirements for cannabinoid receptor probes

B. Thomas, R. Razdan, B. Martin, 1994 .

Pharmacological Characterization of Novel Water-Soluble Cannabinoids

R. Razdan, B. Martin, B. Saha, 2006, Journal of Pharmacology and Experimental Therapeutics.

Pharmacological and behavioral evaluation of alkylated anandamide analogs.

D. R. Compton, R. Razdan, B. Martin, 1995, Life sciences.

Novel compounds that interact with both leukotriene BLT and vanilloid TRPV1 receptors.

D. McHugh, R. Pertwee, R. Razdan, 2005 .

Recent advances in the synthesis of endocannabinoid related ligands.

R. Razdan, A. Mahadevan, 2002, Chemistry and physics of lipids.

Antinociceptive effects of tetrahydrocannabinol side chain analogs: dependence upon route of administration.

R. Razdan, B. Martin, B. Saha, 2000, European journal of pharmacology.

Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists.

R. Razdan, B. Martin, B. Saha, 1999, The Journal of pharmacology and experimental therapeutics.

Potent anandamide analogs: the effect of changing the length and branching of the end pentyl chain.

R. Razdan, B. Martin, W. Ryan, 1997, Journal of medicinal chemistry.

Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore.

S. Mascarella, B. Thomas, R. Razdan, 1996, Journal of medicinal chemistry.

Behavioral comparisons of the stereoisomers of tetrahydrocannabinols.

L. Harris, R. Razdan, B. Martin, 1981, Life sciences.

Total synthesis of 2-Arachidonylglycerol (2-Ara-Gl)

R. Razdan, Lu-na Han, 1999 .

A novel class of potent tetrahydrocannabinols (THCS): 2′-YNE-Δ8- and Δ9-THCS

D. R. Compton, R. Razdan, B. Martin, 1995 .

Lithium-ammonia reduction of tetrahydrocannabinols

R. Razdan, H. Pars, W. Thompson, 1974 .

Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol.

C. Siegel, D. R. Compton, R. Razdan, 1991, Journal of medicinal chemistry.

Synthesis and pharmacological evaluation of amino, azido, and nitrogen mustard analogues of 10-substituted cannabidiol and 11- or 12-substituted delta 8-tetrahydrocannabinol.

P. Little, D. R. Compton, R. Razdan, 1990, Journal of medicinal chemistry.

Synthesis and pharmacological evaluation of mercapto and thioacetyl analogues of cannabidiol and Δ8-tetrahydrocannabinol

P. Little, D. R. Compton, R. Razdan, 1989 .

Evaluation of cannabimimetic effects of structural analogs of anandamide in rats.

R. Razdan, B. Martin, W. Ryan, 1998, European journal of pharmacology.

Synthesis of racemic and optically active .DELTA.9-tetrahydrocannabinol (THC) metabolites

C. Siegel, R. Razdan, G. R. Handrick, 1991 .

Hashish. 26. Factors influencing double-bond stability in cannabinoids

R. Razdan, G. R. Handrick, D. B. Uliss, 1981 .

Structure-activity relationships of the cannabinoids.

R. Razdan, R K Razdan, 1986, NIDA research monograph.

Drugs derived from cannabinoids. 1. Nitrogen analogs, benzopyranopyridines and benzopyranopyrroles.

L. Harris, R. Razdan, H. Pars, 1976, Journal of medicinal chemistry.

Drugs derived from cannabinoids. 3. Sulfur analogs, thiopyranobenzopyrans and thienobenzopyrans.

N. Plotnikoff, R. Razdan, J. Kyncl, 1976, Journal of medicinal chemistry.

A new class of antimalarial drugs: derivatives of benzothiopyrans.

R. Razdan, K. Weinhardt, A. C. Mehta, 1978, Journal of medicinal chemistry.

A probable aziridine radical: mechanism of addition of aziridine to styrenes

R. Razdan, 1969 .

(-)-8beta-hydroxymethyl-delta1-tetrahydrocannabinol: a novel physiologically active analog of delta1-tetrahydrocannabinol.

R. Razdan, W. Dewey, G. R. Handrick, 1976, Experientia.

The Synthesis of N-Vanillyl-arachidonoyl-amide (Arvanil) and its Analogs: An Improved Procedure for the Synthesis of the Key Synthon Methyl 14-Hydroxy-(all-cis)-5,8,11-tetradecatrienoate

V. Marzo, R. Razdan, B. Martin, 2000 .

Regioselective aromatic hydroxylation. An oxidative reaction of arylcopper(I) and lithium diarylcopper(I) ate complexes

R. Razdan, H. Dalzell, G. Lambert, 1982 .

Hashish: synthesis and central nervous system activity of some novel analogues of cannabidiol and oxepin derivatives of delta 9-tetrahydrocannabinol.

L. Harris, R. Razdan, B. Martin, 1985, Journal of medicinal chemistry.

Drugs related to tetrahydrocannabinol

R. Razdan, J. Howes, 1983, Medicinal research reviews.

A Biogenetic-Type Synthesis of Cannabifuran and Dehydrocannabifuran

R. Razdan, V. S. Jorapur, R. P. Duffley, 1984 .

Chapter 3. Hallucinogens

R. Razdan, J. C. Sheehan, 1971 .

Cyclol derivatives related to ergocornine

Anil C. Ghosh, R. Razdan, E. Boger, 1976 .

Hashish. A stereospecific synthesis of (-) delta 1 and (-) delta 1(6) tetrahydrocannabinols.

R. Razdan, G. R. Handrick, 1970, Journal of the American Chemical Society.

Hashish, a novel cannabinoid containing a cyclic peroxide.

R. Razdan, V. V. Kane, 1969, Journal of the American Chemical Society.

Hashish IV: Some acid catalyzed transformations in cannabinoids

R. Razdan, B. A. Zitko, 1969 .

Hashish II: reaction of substituted resorcinols with citral in the presence of pyridine--a proposed mechanism.

R. Razdan, V. V. Kane, 1969, Tetrahedron letters.

Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.

A. Lichtman, R. Razdan, A. Mahadevan, 2009, Drug and alcohol dependence.

Total synthesis of methyl 14-hydroxy-(all-cis)-5,8,11-tetradecatrienoate: A useful intermediate for the synthesis of arachidonic acid analogues

R. Razdan, Lu-na Han, 1998 .

Synthesis of racemic and optically active delta 1 and delta 6 3 4 cis tetra hydro cannabinols

R. Razdan, G. R. Handrick, D. B. Uliss, 1977 .

The Endogenous Brain Constituent N-Arachidonoyl l-Serine Is an Activator of Large Conductance Ca2+-Activated K+ Channels

D. Lovinger, Margaret I Davis, Li Zhang, 2009, Journal of Pharmacology and Experimental Therapeutics.

G Protein-coupled Endothelial Receptor for Atypical Cannabinoid Ligands Modulates a Ca2+-dependent K+ Current*

D. Lovinger, R. Razdan, P. Pacher, 2003, Journal of Biological Chemistry.

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.

T. Bonner, A. Zimmer, É. Mezey, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins

J. A. Comer, T. Greenough, A. Sanchez, 2005, Journal of Virological Methods.

Water-Soluble Derivatives of Δ1 Tetrahydrocannabinol

L. Harris, R. Razdan, W. Dewey, 1972, Science.

Pharmacological potency of R- and S-3′-hydroxy-Δ9-tetrahydrocannabinol: additional structural requirement for cannabinoid activity

L. Harris, R. Razdan, B. Martin, 1984, Pharmacology Biochemistry and Behavior.

Rearrangements of chromanones and dihydrocoumarins by aluminium chloride

R. Razdan, J. Loudon, 1954 .

A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats.

R. Razdan, B. Martin, Sanjitha Kulasegram, 2004, Experimental and clinical psychopharmacology.

CB1 cannabinoid receptor‐mediated modulation of food intake in mice

J. Burston, R. Razdan, B. Martin, 2005, British journal of pharmacology.

Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide.

C. Breivogel, T. Bisogno, V. Marzo, 2000, European journal of pharmacology.

Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2'-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide.

N. Kaminski, R. Razdan, S. Yea, 2005, Toxicology and applied pharmacology.

Assessment of structural commonality between tetrahydrocannabinol and anandamide.

B. Thomas, R. Razdan, B. Martin, 2002, European journal of pharmacology.

An expedient and efficient synthesis of an optically active terpene synthon for Δ9-cannabinoids

C. Siegel, R. Razdan, P. Gordon, 1991 .

Unique analogues of anandamide: arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas.

R. Razdan, B. Martin, M. Abood, 1999, Journal of medicinal chemistry.

N-Arachidonyl Maleimide Potentiates the Pharmacological and Biochemical Effects of the Endocannabinoid 2-Arachidonylglycerol through Inhibition of Monoacylglycerol Lipase

D. Selley, J. Burston, R. Razdan, 2008, Journal of Pharmacology and Experimental Therapeutics.

Stereospecific intramolecular epoxide cleavage by phenolate anion. Synthesis of novel and biologically active cannabinoids

R. Razdan, D. B. Uliss, H. Dalzell, 1975 .

Task specificity of cross-tolerance between Delta9-tetrahydrocannabinol and anandamide analogs in mice.

R. Razdan, J. Wiley, W. Dewey, 2005, European journal of pharmacology.

Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB(1) receptor antagonist.

C. Breivogel, M. Cascio, D. Bolognini, 2011, European journal of pharmacology.

A Procedure for the Conversion of Cannabidiol into 12β-Substituted Tetrahydrocannabinols (THC's): Synthesis of 12β-Hydroxy-ΔβTHC1

R. Razdan, V. S. Jorapur, R. P. Duffley, 1984 .

A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid.

T. Bisogno, M. Grier, V. Di Marzo, 2002, The Journal of pharmacology and experimental therapeutics.

Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands.

L. Petrocellis, T. Bisogno, V. Di Marzo, 2001, Biochemical and biophysical research communications.

Synthesis of (+)- and (-)-2-methylarachidonyl-2'-fluoroethylamide (O-689)

R. Razdan, B. Martin, W. Ryan, 1997 .

Heterocyclic Analogs of the Cannabinoids

R. Razdan, H. Pars, 1976 .

Pharmacology of some Marijuana Constituents and Two Heterocyclic Analogues

L. Harris, R. Razdan, J. Kennedy, 1970, Nature.

Physiologically Active Nitrogen Analogs of Tetrahydrocannabinols. Tetrahydrobenzopyrano[3,4-d]pyridines

R. Razdan, H. Pars, J. Keller, 1966 .

A biosynthetic pathway for anandamide

Bill X. Huang, Hee-Yong Kim, Lei Wang, 2006, Proceedings of the National Academy of Sciences.

Drugs derived from cannabinoids. 2. Basic esters of nitrogen and carbocyclic analogs.

N. Plotnikoff, R. Razdan, J. Kyncl, 1976, Journal of medicinal chemistry.

Hashish: Synthesis of d1-δ1,6--tetrahydrocannabinol (THC)

R. Razdan, G. R. Handrick, D. B. Uliss, 1975 .

Hashish. Synthesis of 7-hydroxy-delta-tetrahydrocannabinol (THC). An important active metabolite of delta-THC in man.

R. Razdan, D. B. Uliss, H. Dalzell, 1973, Journal of the American Chemical Society.

Hashish. A simple one-step synthesis of (-)-delta1-tetrahydrocannabinol (THC) from p-mentha-2,8-dien-1-ol and olivetol.

R. Razdan, G. R. Handrick, H. Dalzell, 1974, Journal of the American Chemical Society.

Constituents of hashish. A novel reaction of olivetol with citral in the presence of pyridine. Total synthesis of dl-cannabicyclol and dl-cannabichromene.

R. Razdan, V. V. Kane, 1968, Journal of the American Chemical Society.

SR-141716A-induced stimulation of locomotor activity A structure–activity relationship study

C. Bass, M. Grier, G. Griffin, 2002, Pharmacology Biochemistry and Behavior.

QSAR analysis of Delta(8)-THC analogues: relationship of side-chain conformation to cannabinoid receptor affinity and pharmacological potency.

S. Mascarella, B. Thomas, R. Razdan, 2000, Journal of medicinal chemistry.

Endothelial nitric oxide synthase is regulated by ERK phosphorylation at Ser602

Jonathan L. McMurry, J. McMurry, R. Razdan, 2014, Bioscience reports.

Evaluation of the role of the arachidonic acid cascade in anandamide's in vivo effects in mice.

R. Razdan, B. Martin, J. Wiley, 2006, Life sciences.

Novel cannabinol probes for CB1 and CB2 cannabinoid receptors.

C. Siegel, R. Razdan, B. Martin, 2000, Journal of medicinal chemistry.

Diels-Alder reaction of β-dihydrothebaine and its 4-phenyl ether with methyl vinyl ketone: synthesis of 6,14-exo-ethenomorphinans

Anil C. Ghosh, R. Razdan, P. Herlihy, 1983 .

Total Synthesis of 2-Arachidonylglycerol (2-Ara-Gl).

R. Razdan, Lu-na Han, 1999 .

SYNTHESIS OF RACEMIC AND OPTICALLY ACTIVE Δ1‐ AND Δ6‐3,4‐CIS‐TETRAHYDROCANNABINOLS. PART XIX

R. Razdan, G. R. Handrick, D. B. Uliss, 1977 .

A novel class of potent tetrahydrocannabinols (THCS): 2'-yne-delta 8- and delta 9-THCS.

D. R. Compton, R. Razdan, B. Martin, 1995, Life sciences.

An optically active terpenic synthon for .DELTA.9-cannabinoids: synthesis of (-)-11-hydroxy-.DELTA.9-tetrahydrocannabinol (THC) and its 1',1'-dimethylheptyl analog

C. Siegel, R. Razdan, P. Gordon, 1989 .

A cannabinoid with cardiovascular activity but no overt behavioral effects

L. Harris, R. Razdan, B. Martin, 1977, Experientia.

Novel pyrazole cannabinoids: insights into CB(1) receptor recognition and activation.

M. Grier, R. Razdan, B. Martin, 2001, The Journal of pharmacology and experimental therapeutics.

HASHISH PART 10, A SIMPLE ONE-STEP SYNTHESIS OF (-)-DELTA(1)-TETRAHYDROCANNABINOL (THC) FROM P-MENTHA-2,8-DIEN-1-OL AND OLIVETOL

R. Razdan, G. R. Handrick, H. Dalzell, 1974 .

The Synthesis of N‐Vanillyl‐arachidonoyl‐amide (Arvanil) and Its Analogues: An Improved Procedure for the Synthesis of the Key Synthon Methyl 14‐Hydroxy‐(all‐cis)‐5,8,11‐tetradecatrienoate.

V. Marzo, R. Razdan, B. Martin, 2001 .

The Endogenous Brain Constituent N -Arachidonoyl L -Serine Is an Activator of Large Conductance Ca 2 (cid:1) -Activated K (cid:1) Channels

D. Lovinger, R. Razdan, D. Osei-Hyiaman, 2008 .

3'-Hydroxy- and (+/-)-3',11-dihydroxy-delta 9-tetrahydrocannabinol: biologically active metabolites of delta 9-tetrahydrocannabinol.

L. Harris, R. Razdan, B. Martin, 1982, Journal of medicinal chemistry.

Total synthesis of (.+-.)-3-deoxy-7,8-dihydromorphinone

R. Razdan, J. Marshall, R. Minns, 1982 .

A terpenic synthon for .DELTA.1-cannabinoids

R. Razdan, G. R. Handrick, H. Dalzell, 1978 .

Hashish: Synthesis of Δ9-tetrahydrocannabinol (THC), a metabolite ofΔ 9-THC1

R. Razdan, H. Dalzell, G. Lambert, 1981, Experientia.

A TERPENIC SYNTHON FOR Δ1-CANNABINOIDS

R. Razdan, G. R. Handrick, H. Dalzell, 1978 .

CHEMISTRY AND STRUCTURE-ACTIVITY RELATIONSHIPS OF CANNABINOIDS: AN OVERVIEW

R. Razdan, 1984 .

Hashish: Synthesis of (−)-Δ9-tetrahydrocannabinol (THC) and its biologically potent metabolite 3′-hydroxy-Δ9-THC.☆

R. Razdan, G. R. Handrick, H. Dalzell, 1979 .